Laser Resurfacing for Precancerous Skin Lesions
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, if you are on systemic hormone replacement therapy, you cannot participate in the trial.
What data supports the effectiveness of the treatment Fractionated Laser Resurfacing for precancerous skin lesions?
Research shows that fractional laser resurfacing, including Fraxel and fractionated CO2 lasers, is effective for treating various skin conditions like scars and photoaging (skin damage from the sun). These treatments create tiny, controlled injuries in the skin, which helps stimulate healing and improve skin appearance, suggesting potential benefits for precancerous lesions as well.12345
Is laser resurfacing safe for treating skin conditions?
How is Fractionated Laser Resurfacing different from other treatments for precancerous skin lesions?
Fractionated Laser Resurfacing is unique because it uses a laser to create tiny zones of skin damage surrounded by healthy tissue, which helps the skin heal faster and stimulates new collagen growth. This method offers a better balance between safety and effectiveness compared to traditional laser treatments, making it a novel option for skin resurfacing.15101112
What is the purpose of this trial?
The purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing at the Dayton Veterans Administration dermatology clinic. This study is also testing if a photograph of the skin can be used to predict where the AKs and an skin cancers will form.
Research Team
Jeffrey Travers, MD, PhD
Principal Investigator
Wright State University
Eligibility Criteria
This trial is for older adults with active precancerous skin lesions known as actinic keratosis. Participants should have a history of these lesions and be at risk for developing skin cancer. Specific eligibility criteria are not provided, but typically include being in good health and meeting certain medical parameters.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Fractionated Laser Resurfacing (FLR) on one forearm/wrist to prevent actinic keratosis and skin cancer
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Fractionated Laser Resurfacing
Fractionated Laser Resurfacing is already approved in United States, European Union, Canada for the following indications:
- Wrinkles
- Scars
- Sun damage
- Melasma
- Actinic keratosis
- Non-melanoma skin cancers
- Wrinkles
- Scars
- Sun damage
- Melasma
- Actinic keratosis
- Non-melanoma skin cancers
- Wrinkles
- Scars
- Sun damage
- Melasma
- Actinic keratosis
- Non-melanoma skin cancers
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wright State University
Lead Sponsor